References
- 1. R. Pivonello, M.C. de Martino, M. de Leo,L. Tauchmanovà, A. Faggiano, G. Lombardi, Cushing’s syndrome: Aftermath of the cure, Arq Bras Endocrinol Metabol, 51 (2007), pp. 1381-1391.10.1590/S0004-27302007000800025
- 2. E. Valassi, I. Crespo, A. Santos, S.M. Webb, Clinical consequences of Cushing’s syndrome, Pituitary, 15 (2012), pp. 319-329.2252761710.1007/s11102-012-0394-822527617
- 3. R.A. Feelders, S.J. Pulgar, A. Kempel, A.M. Pereira, The burden of Cushing’s disease: clinical and health-related quality of life aspects, Eur J Endocrinol, 167 (2012), pp. 311-326.10.1530/EJE-11-1095
- 4. E. Valassi, A. Santos, M. Yaneva, M. Toth, C.J. Strasburger, P. Chanson, The European Registry on Cushing’s syndrome: 2-year experience. Baseline demographic and clinical characteristics, Eur J Endocrinol, 165 (2011), pp. 383-392.10.1530/EJE-11-0272
- 5. A. Colao, R. Pivonello, S. Spiezia, A. Faggiano, D. Ferone, M. Filippella, Persistence of increased cardiovascular risk in patients with Cushing’s disease after five years of successful cure, J Clin Endocrinol Metab, 84 (1999), pp. 2664-2672.10.1210/jcem.84.8.5896
- 6. Y. Liu, Y. Nakagawa, Y. Wang, R. Li, X. Li, T. Ohzeki, Leptin activation of corticosterone production in hepatocytes may contribute to the reversal of obesity and hyperglycemia in leptin-deficient ob/ob mice, Diabetes, 52 (2003), pp. 1409-1416.10.2337/diabetes.52.6.14091276595112765951
- 7. M.J. Barahona, N. Sucunza, E. Resmini, J.M. Fernández-Real, W. Ricart, J.M. Moreno-Navarrete, Persistent body fat mass and inflammatory marker increases after long-term cure of Cushing’s syndrome, J Clin Endocrinol Metab, 94 (2009), pp. 3365-3371.1950910110.1210/jc.2009-076619509101
- 8. Bujalska IJ, Kumar S, Stewart PM. Does central obesity reflect Cushing’s disease of the omentum? Lancet. 1997;349:1210–3.10.1016/S0140-6736(96)11222-8
- 9. Andrews RC, Herlihy O, Livingstone DE. et al. Abnormal cortisol metabolism and tissue sensitivity to cortisol in patients with glucose intolerance. J Clin Endocrinol Metab. 2002;87:5587–93.10.1210/jc.2002-02004812466357
- 10. Reynolds RM, Chapman KE, Seckl JR. et al. Skeletal muscle glucocorticoid receptor density and insulin resistance. JAMA. 2002;287:2505–6.10.1001/jama.287.19.250512020330
- 11. M. De Leo, R. Pivonello, R.S. Auriemma, A. Cozzolino, P. Vitale, C. Simeoli, Cardiovascular disease in Cushing’s syndrome: heart v ersus vasculature, Neuroendocrinology, 92 (2010), pp. 50-54.10.1159/00031856620829618
- 12. Giraldi FP, Moro M, Cavagnini F. Study Group on the Hypothalamo-Pituitary-Adrenal Axis of the Italian Society of Endocrinology. Gender-related differences in the presentation and course of Cushing’s disease. J Clin Endocr Metab 2003;88:1554–1558.10.1210/jc.2002-02151812679438
- 13. Mancini T, Kola B, Concettoni C, Boscaro M, Mantero F, Arnaldi G. Hypertension in patients with Cushing’s syndrome: Evidence for gender difference in 11β hydroxysteroid dehydrogenase type 2 activity. The Endocrine Society 85nd Annual Meeting, Philadelphia, P2-606, 2003;454.
- 14. Magiakou MA, Mastrokaros G, Olfield EA, Gomez MT, Doppman JL, Cutler GBJ, Nieman LK. Chrousos GP Cushing’s syndrome in children and adolescents: Presentation, diagnosis and therapy. New England J Med 1994;331:629–636.10.1056/NEJM1994090833110028052272
- 15. Biglieri EG, Kater CE, Mantero F. Adrenocortical forms of human hypertension. In: Laragh, Brenner (Eds), Hypertension, 2nd edn. Raven Press, 1995:2145.
- 16. Arnaldi G, Mancini T, Tirabassi G. et al. Advances in the epidemiology, pathogenesis, and management of Cushing’s syndrome complications. J Endocrin Invest. 2012;35:434–38.10.1007/BF0334543122652826
- 17. Magiakou MA, Smyrnaki P, Chrousos GP: Hypertension in Cushing’s syndrome. Best Pract Res Clin Endocrinol Metab 2006;20:467–482.10.1016/j.beem.2006.07.00616980206
- 18. Pecori Giraldi F, Toja PM, De Martin M, Maronati A, Scacchi M, Omboni S, Cavagnini F, Parati G: Circadian blood pressure profile in patients with active Cushing’s disease and after long-term cure. Horm Metab Res 2007;39:908–914.10.1055/s-2007-992813
- 19. Muiesan ML, Lupia M, Salvetti M, Grigoletto C, Sonino N, Boscaro M, Rosei EA, Mantero F, Fallo F: Left ventricular structural and functional characteristics in Cushing’s syndrome. J Am Coll Cardiol 2003;41:2275–2279.10.1016/S0735-1097(03)00493-5
- 20. Pereira AM, Delgado V, Romijn JA, Smit JW, Bax JJ, Feelders RA: Cardiac dysfunction is reserved upon successful treatment of Cushing’s syndrome. Eur J Endocrinol 2010;162:331–340.10.1530/EJE-09-062119933822
- 21. B. Van Zanne,E. Nur,A. Squizzato,O.M. Dekkers,M.T. Twickler,E. Fliers, Hypercoagulable state in Cushing’s syndrome: a systematic review, J Clin Endocrinol Metab, 94 (2009), pp. 2743-2750.10.1210/jc.2009-029019454584
- 22. L. Manetti,F. Bogazzi,C. Giovannetti,V. Raffaelli,M. Genovesi,G. Pellegrini, Changes in coagulation indexes and occurrence of venous thromboembolism in patients with Cushing’s syndrome: results from a prospective study before and after surgery, Eur J Endocrinol, 163 (2010), pp. 783-791.10.1530/EJE-10-0583
- 23. Ermetici F, Malavazos AE, Corbetta S, Eller-Vainicher C, Cannavò S, Corsi MM, Ambrosi B: Soluble adhesion molecule levels in patients with Cushing’s syndrome before and after cure. J Endocrinol Invest 2008;31:389–392.10.1007/BF0334638118560255
- 24. Kristo C, Ueland T, Godang K, Aukrust P, Bollerslev J: Biochemical markers for cardiovascular risk following treatment in endogenous Cushing’s syndrome. J Endocrinol Invest 2008;31:400–405.10.1007/BF0334638318560257
- 25. Boscaro M, Sonino N, Scarda A, Barzon L, Fallo F, Sartori MT, Patrassi GM, Girolami A: Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing’s syndrome. J Clin Endocrinol Metab 2002;87:3662–3666.10.1210/jcem.87.8.8703
- 26. Terzolo M, Allasino B, Bosio S, Brusa E, Daffara F, Ventura M, Aroasio E, Sacchetto G, Reimondo G, Angeli A, Camaschella C: Hyperhomocysteinemia in patients with Cushing’s syndrome. J Clin Endocrinol Metab 2004;89:3745–3751.10.1210/jc.2004-0079
- 27. Faggiano A, Melis D, Alfieri R, De Martino M, Filippella M, Milone F, Lombardi G, Colao A, Pivonello R: Sulfur amino acids in Cushing’s disease: insight homocysteine and taurine levels in patients with active and cured disease. J Clin Endocrinol Metab 2005;90:6616–6622.10.1210/jc.2005-065616174722
- 28. M.J. Barahona,E. Resmini,D. Viladés,G. Pons-Lladó,R. Leta,T. Puig, Coronary artery disease detected by multislice computed tomography in patients after long-term cure of Cushing’s syndrome, J Clin Endocrinol Metab, 98 (2013), pp. 1093-1099.10.1210/jc.2012-354723393183
- 29. Baykan M, Erem C, Gedikli O. et al. Impairment of flow-mediated vasodilatation of brachial artery in patients with Cushing’s Syndrome. Endocrine. 2007;31:300–4.10.1007/s12020-007-0033-817906379
- 30. Prázný M, Jezková J, Horová E. et al. Impaired microvascular reactivity and endothelial function in patients with Cushing’s syndrome: influence of arterial hypertension. Physiol Res. 2008;57:13–22.10.33549/physiolres.93112617223725
- 31. Neary NM, Booker OJ, Abel BS. et al. Hypercortisolism is associated with increased coronary arterial atherosclerosis: analysis of noninvasive coronary angiography using multidetector computerized tomography. J Clin Endocrinol Metab. 2013;98:2045–52.10.1210/jc.2012-3754364459823559084
- 32. Schneider HJ, Dimopoulou C, Stalla GK, Reincke M & Schopohl J. Discriminatory value of signs and symptoms in Cushing’s syndrome revisited: what has changed in 30 years? Clinical Endocrinology 2013 78 153–154.10.1111/j.1365-2265.2012.04488.x22775352
- 33. Shen J, Sun M, Zhou B & Yan J. Nonconformity in the clinical practice guidelines for subclinical Cushing’s syndrome: which guidelines are trustworthy? European Journal Endocrinology 2014 171 421–431.10.1530/EJE-14-034524986532
- 34. Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Alì A, Giovagnetti M, Opocher G & Angeli A. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. Journal of Clinical Endocrinology and Metabolism 2000 85 637–644.10.1210/jc.85.2.637
- 35. Terzolo M, Pia A, Alì A, Osella G, Reimondo G, Bovio S, Daffara F, Procopio M, Paccotti P, Borretta G et al. Adrenal incidentaloma: a new cause of the metabolic syndrome? Journal of Clinical Endocrinology and Metabolism 2002 87 998–1003.10.1210/jcem.87.3.827711889151
- 36. Chiodini I. Clinical review: diagnosis and treatment of subclinical hypercortisolism. Journal of Clinical Endocrinology and Metabolism 2011 96 1223–1236.10.1210/jc.2010-272221367932
- 37. Shen J, Sun M, Zhou B & Yan J. Nonconformity in the clinical practice guidelines for subclinical Cushing’s syndrome: which guidelines are trustworthy? European Journal Endocrinology 2014 171 421–43110.1530/EJE-14-0345